MedTrace Logo

Intramedullary Devices for the Treatment of Unstable Pertrochanteric Fractures

NCT02074969 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2014-03-03

No results posted yet for this study

Summary

The purpose of this study is to assess the differences between two different types of devices for the treatment of unstable pertrochanteric hip fractures. The hypothesis of this study is, that patients who are treated with the proximal femoral Nail Antirotation (PFNA) have a better outcome and lower complication rates than patients treated with the Gamma Nail (GN3).

Conditions

  • Fractures

Interventions

DEVICE

Gamma Nail 3

Patients who have sustained an unstable pertrochanteric hip fracture are getting treated by Gamma Nail 3.

DEVICE

PFNA

Patients who have sustained an unstable pertrochanteric hip fracture are getting treated by PFNA.

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Harald K. Widhalm, M.D. · Department of Trauma, Medical University of Vienna, Austria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2010-12-31
Completion
2012-05-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02074969 on ClinicalTrials.gov